Revisiting Interventions in Aseptic Processing - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Revisiting Interventions in Aseptic Processing
The authors revisit their previous effort to refine the terms that describe interventions and to dispel confusion that arose after the original article was published.


Pharmaceutical Technology
Volume 35, Issue 4, pp. 69-72

Intervention management

The importance of interventions in aseptic processing requires a degree of structure to be established to ensure that practices are consistent across the organization. The authors recommend that the following sequence of activities be used to accomplish this.

1. Conduct an informal poll of the entire aseptic processing staff about the interventions they perform. This poll should ask about inherent and corrective interventions for all processing lines. Surprising as it might seem, the list of interventions will differ from individual to individual.

2. The interventions should be categorized as inherent or corrective for each line, process, or configuration. Each list should be reviewed in detail because some of the identified interventions may represent an inordinate contamination risk. Production, quality, and microbiology experts should determine which interventions should be retained as acceptable practice for that process. Heroic interventions should be avoided.


Intervention procedures
3. In conjunction with the aseptic operators, the interventions should be defined with adequate detail to ensure that all personnel can execute them in a nearly identical manner (see sidebar, "Intervention procedures"). Technically competent individuals should evaluate the individual intervention procedures to minimize their contamination potential. The procedure should specify the number or location of any components or filled containers to be removed from the line. The extent of the line clearance should vary with the location and severity of the intervention. For example, if an unfilled vial falls over on the line without breaking, its removal may be sufficient to return the line to full operation.†† Were an unstoppered, filled vial to break and spill, the extent of the necessary line clearance and interventional activity would increase.

4. Once a preferred approach for executing an intervention has been chosen, it should be incorporated into an SOP. Procedures for corrective interventions must allow for flexibility to address their variability.

5. The aseptic operators should be trained in the various intervention procedures they are expected to perform. Videos of execution and sequential photographs of the interventions can be beneficial in this effort.

6. The batch records for production lots should maintain a record of each corrective intervention performed. These records should support the frequency of corrective interventions during process simulation. Inherent interventions already are defined by other procedures for operation and monitoring of the process, so recording their execution in the lot record may not be necessary.

7. When the need for a new intervention arises, the supervisory decision may be not to proceed with the new intervention. In these circumstances, a lot-termination procedure can help secure product materials.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
44%
Facility/environment problems
0%
Process development problems
11%
Production equipment downtime
11%
Raw material supply problems
11%
Regulatory restrictions
0%
Business decisions to limit production
22%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Patent Settlements Become More Risky
Praise and Perils for Biotechnology Patent Policy
Risk-Mitigation Strategies in Drug Manufacturing for Emerging Markets
Quality Focus: Ensuring Raw Material Transparency
Advertising of Prescription Drugs  Keeping it Honest and Balanced
Source: Pharmaceutical Technology,
Click here